Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
31.03%
0%
31.03%
6 Months
40.74%
0%
40.74%
1 Year
9.62%
0%
9.62%
2 Years
-8.8%
0%
-8.8%
3 Years
-17.39%
0%
-17.39%
4 Years
-47.47%
0%
-47.47%
5 Years
28.09%
0%
28.09%
NetScientific Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
21.52%
EBIT Growth (5y)
-3.49%
EBIT to Interest (avg)
-3.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.08
Tax Ratio
1.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.99
EV to EBIT
-4.28
EV to EBITDA
-4.75
EV to Capital Employed
0.99
EV to Sales
6.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-23.18%
ROE (Latest)
-22.83%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
1.00
1.10
-9.09%
Operating Profit (PBDIT) excl Other Income
-4.20
-2.80
-50.00%
Interest
0.10
0.00
Exceptional Items
-0.30
-0.10
-200.00%
Consolidate Net Profit
-3.70
-2.90
-27.59%
Operating Profit Margin (Excl OI)
-4,482.10%
-2,736.20%
-174.59%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is -9.09% vs 175.00% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -27.59% vs -26.09% in Dec 2021
About NetScientific Plc 
NetScientific Plc
Pharmaceuticals & Biotechnology
NetScientific PLC is a United Kingdom-based healthcare intellectual property (IP) commercialization company. The Company is focused on technologies and companies that treats chronic disease and improve the health and well-being. The Company funds, develops, and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in United States and Europe with a primary focus on digital health, diagnostics and therapeutics. The Company is an investor providing management support, including technical guidance, administrative support, IP and commercial knowhow. The Company has investments in approximately 15 portfolio companies in the United States, United Kingdom and Israel in industrial high-tech, energy and healthcare. The Company’s subsidiaries include NetScientific UK Limited, NetScientific America, Inc and Glycotest, Inc.
Company Coordinates 
Company Details
PO Box 76075 , LONDON None : EC3P 3DX
Registrar Details






